Rising Demand in the Secukinumab Market: A Look Ahead to 2030

The Secukinumab market is experiencing a major transformation as the demand for targeted therapies continues to rise globally. Secukinumab, a biologic drug that inhibits interleukin-17A (IL-17A), has gained wide recognition for its success in treatin...